医脉通导读本项Cochrane系统评价提示，无论抗抑郁药整体还是SSRIs、SNRIs、其他抗抑郁药，针对广泛性焦虑障碍（GAD）的疗效和可接受度呈现出高度一致和稳健的模式，即：1. 有效率显著高于安慰剂；2. 全因停药率与安慰剂无显著差异；3.

A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

A Cochrane review has concluded that antidepressants are more effective than placebo in reducing the symptoms of generalised anxiety disorder (GAD) in the short term.1 The National Institute for ...

including numerous selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), are associated with weight gain. For example, a large-scale systematic ...

Antidepressants may also be helpful in managing urinary incontinence (unintentionally passing urine) and stress incontinence (passing urine when there’s pressure on the bladder from coughing, jumping, ...

SSRIs and selective norepinephrine reuptake inhibitors (SNRIs) have been extensively studied for the management of hot flashes with varying results. [1] In this well-done trial, escitalopram at ...

MDD3001 enrolled MDD patients who had not responded well to standard SSRI and SNRI antidepressants and had significant sleep disturbance. Compared to placebo, seltorexant achieved significant ...